Boston Scientific is trading at $47.72, down -4.30%, after disclosing a cybersecurity incident identified on August 25, 2026.
- The disruption affects information systems and business applications supporting operations, including customer-order processing and product shipments
- The company is investigating with third-party cybersecurity experts
- The incident’s full operational and financial impact remains unknown, and no restoration timeline has been provided